Literature DB >> 31289922

The Utility of Esophageal Motility Testing in Gastroesophageal Reflux Disease (GERD).

Stephanie Garbarino1, Anthony Horton1, Amit Patel2.   

Abstract

PURPOSE OF REVIEW: Here, we discuss how esophageal motor testing plays important roles in patients with suspected gastroesophageal reflux disease (GERD). In addition to guiding appropriate placement of catheters for ambulatory reflux monitoring, esophageal high-resolution manometry (HRM) rules out confounding diagnoses, such as achalasia spectrum disorders, that can present with symptoms similar to that of GERD, but are managed very differently. RECENT
FINDINGS: HRM performed with impedance in the post-prandial setting (PP-HRIM) can assess for rumination syndrome or supragastric belching, which should be directed towards behavioral interventions. The recent GERD Classification of Motor Function recommends a hierarchical approach, focusing on (1) the esophagogastric junction (EGJ), (2) the esophageal body, and (3) esophageal contraction reserve, which can be assessed with provocative maneuvers at HRM, such as multiple rapid swallows (MRS). This approach can inform the appropriate tailoring of antireflux surgery. Novel esophageal motility metrics, such as the EGJ-contractile integral from HRM, or post-reflux swallow-induced peristaltic wave indices from 24-h pH-impedance monitoring, may also assist with GERD diagnosis. Assessment of esophageal motor function can contribute in a significant manner to the care of patients with suspected GERD, particularly when esophageal symptoms do not improve with antisecretory therapy, and/or when surgical or endoscopic antireflux therapies are under consideration.

Entities:  

Keywords:  Achalasia; Antireflux surgery (ARS); Esophageal function testing; Esophageal high-resolution manometry (HRM); Esophageal motor testing; Gastroesophageal reflux disease (GERD); High-resolution impedance manometry (HRIM); Multiple rapid swallows (MRS)

Year:  2019        PMID: 31289922     DOI: 10.1007/s11894-019-0704-7

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  6 in total

1.  ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing.

Authors:  C Prakash Gyawali; Dustin A Carlson; Joan W Chen; Amit Patel; Robert J Wong; Rena H Yadlapati
Journal:  Am J Gastroenterol       Date:  2020-09       Impact factor: 12.045

2.  Factors affecting the treatment outcomes of laparoscopic fundoplication for erosive reflux esophagitis: findings of esophageal pathological function tests.

Authors:  Kazuto Tsuboi; Fumiaki Yano; Nobuo Omura; Masato Hoshino; Se-Ryung Yamamoto; Shunsuke Akimoto; Takahiro Masuda; Yuki Sakashita; Toru Ikegami
Journal:  Surg Today       Date:  2021-01-25       Impact factor: 2.549

3.  Atypical dysphagia with end-stage oesophageal disease 30 years post Angelchik device placement in a 72-year-old man.

Authors:  Mattan Arazi; Brian Vadasz; Benjamin Person; Ronen Galili; Jason Lefkowitz
Journal:  BMJ Case Rep       Date:  2020-01-08

4.  Clinical Characteristics of Esophageal Motility Disorders in Patients With Heartburn.

Authors:  Satsuki Takahashi; Tomoaki Matsumura; Tatsuya Kaneko; Mamoru Tokunaga; Hirotaka Oura; Tsubasa Ishikawa; Ariki Nagashima; Wataru Shiratori; Naoki Akizue; Yuki Ohta; Atsuko Kikuchi; Mai Fujie; Keiko Saito; Kenichiro Okimoto; Daisuke Maruoka; Tomoo Nakagawa; Makoto Arai; Jun Kato; Naoya Kato
Journal:  J Neurogastroenterol Motil       Date:  2021-10-30       Impact factor: 4.924

5.  Utilizing multimodal imaging to visualize potential mechanism for sudden death in epilepsy.

Authors:  Ranajay Mandal; Ryan Budde; Georgia L Lawlor; Pedro Irazoqui
Journal:  Epilepsy Behav       Date:  2021-07-05       Impact factor: 3.337

6.  Diagnostic yield and reliability of post-prandial high-resolution manometry and impedance-ph for detecting rumination and supragastric belching in PPI non-responders.

Authors:  Kelli DeLay; John E Pandolfino; Sabine Roman; C Prakash Gyawali; Edoardo Savarino; Michael Tye; Alexander Kaizer; Rena Yadlapati
Journal:  Neurogastroenterol Motil       Date:  2021-03-09       Impact factor: 3.960

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.